Latest News & Features
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/5e5d0c10-4799-11f0-a809-0b3fd081904a-Kathi%20Vidal(3).webp)
Americas
Two decisions by acting USPTO director Coke Morgan Stewart have “damaging” consequences, warns Vidal | Stewart kickstarts campaign of implied criticism of predecessor’s record. 12 June 2025
Careers
Three seasoned lawyers with experience in biotech, pharmaceutical, and medical device patent matters join the firm's practice in Washington, DC and Chicago offices. 12 June 2025
Biotechnology
Judges uphold PTAB’s finding that two Agilent patents are invalid | All claims of patents, which cover guide RNAs, found to be anticipated by prior art. 12 June 2025
Americas
US appeals court confirms validity of Acadia's Nuplazid patents | Decision fends off generics from MSN Laboratories and Aurobindo Pharma until 2030s. 10 June 2025
Americas
Office’s acting director lifts severe penalties against patent owner following Federal Circuit remand | Issues separate decision highlighting consequences of “lengthy awareness” of patent portfolio. 10 June 2025
Americas
Biotech company convinces judges over claim construction interpretation | Alnylam “acted as lexicographer” regarding a claim term | Win comes as Moderna suffers economic challenges. 5 June 2025
Big Pharma
Companies face increasingly complex decisions over what IP to use, particularly when collaborating. Muireann Bolger hears the dos and don’ts of protection from senior counsel. 5 June 2025
Americas
With nearly four decades of patent law experience—including decades at the USPTO—new senior patent counsel joins the firm’s Washington, DC office, bringing expertise in biotech, pharma, and chemical engineering. 5 June 2025
Europe
Survey launched ahead of LSIPR’s LSPN Europe conference | Seeks input on AI impact, Brexit, and Unitary Patent system | Focuses on patent challenges in pharma, biotech, medical devices, diagnostics to shape conference discussions in London. 4 June 2025
Americas
New York court finds Ethicon breached agreement with ChemImage over advanced imaging technologies | Parties dispute damages for IP ‘impairment’. 3 June 2025